phenylalanine has been researched along with Hypoglycemia in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (28.00) | 18.7374 |
1990's | 1 (4.00) | 18.2507 |
2000's | 15 (60.00) | 29.6817 |
2010's | 1 (4.00) | 24.3611 |
2020's | 1 (4.00) | 2.80 |
Authors | Studies |
---|---|
Kejun, W; Libin, L; Lijing, W; Linxi, W; Liqin, Q; Lishan, H; Mengjun, Z; Sujie, K; Xiaohong, L; Xiaoying, L; Zhidong, Z | 1 |
Bilker, WB; Brensinger, CM; Chiang, C; Han, X; Hennessy, S; Leonard, CE; Li, L | 1 |
Juurinen, L; Kauppinen-Mäkelin, R; Kock, T; Kotronen, A; Lanki, H; Leppävuori, E; Nikkilä, K; Saltevo, J; Teikari-Myyrä, T; Tiikkainen, M; Yki-Järvinen, H | 1 |
Cornelius, V; Kasliwal, R; Shakir, SA; Vlckova, V; Wilton, L | 1 |
Davis, SN | 1 |
Ball, M; Dickinson, S; Hershon, K; Holmes, D; Saloranta, C | 1 |
Kikuchi, M; Notoya, Y | 1 |
Iizuka, K; Imamura, M; Mori, M; Nagai, T | 1 |
CRAWFORD, JD; DODGE, PR; KNAPP, J; MANCALL, E; PAINE, RS | 1 |
CARNEVALI, R; POLI, E; RAINERI, P | 1 |
Haslbeck, M; Jakob, S; Kellerer, M; Linn, T | 1 |
Ishida, H; Kadowaki, T; Kawamori, R | 1 |
Groop, LC; Honkanen, EH; Isomaa, B; Sarelin, L; Tuomi, T | 1 |
Hirose, T; Kawamori, R; Kawasumi, M; Kurebayashi, S; Tanaka, Y; Watada, H | 1 |
Mori, Y | 1 |
Collober-Maugeais, C; Cressier, F; Pecher, E; Ristic, S; Tang, P | 1 |
Baron, MA; Gerich, JE; Jean-Louis, L; Marcellari, A; Purkayastha, D; Schwarz, SL | 1 |
Bryant, SM; Sherk, DK | 1 |
Borrow, P; de la Torre, JC; Oldstone, MB; Teng, MN | 1 |
Bell, PA; Boettcher, BR; Dunning, BE; Fanelli, B; Geisse, S; Hu, S; Schmitz, R; Wang, S | 1 |
Justice, P; Michals, K; Wong, PW; Ziyai, F | 1 |
Steiner, DF | 1 |
Bickel, H; Lutz, P; Nützenadel, W | 1 |
Drásilová, L; Kaniová, V; Mrskos, A; Podhradská, O; Snopková, J | 1 |
Fishman, WH; Sie, HG | 1 |
4 review(s) available for phenylalanine and Hypoglycemia
Article | Year |
---|---|
Advances in oral therapy for type 2 diabetes.
Topics: Acarbose; Administration, Oral; Blood Glucose; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Metformin; Nateglinide; Phenylalanine; Piperidines; Randomized Controlled Trials as Topic; Thiazolidinediones; United States; Weight Gain | 2000 |
[Nateglinide].
Topics: Animals; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Nateglinide; Phenylalanine | 2002 |
[Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy].
Topics: 1-Deoxynojirimycin; Acarbose; Aged; Blood Glucose; Carbamates; Contraindications; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Fasting; Follow-Up Studies; Germany; Glucosamine; Glyburide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Imino Pyranoses; Insulin; Metformin; Middle Aged; Nateglinide; Obesity; Patient Compliance; Phenylalanine; Pioglitazone; Piperidines; Practice Guidelines as Topic; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Time Factors | 2003 |
[Postprandial hypoglycemia].
Topics: Acarbose; Cyclohexanes; Diet, Carbohydrate-Restricted; Dietary Fiber; Dumping Syndrome; Enzyme Inhibitors; Gastrectomy; Glucose Intolerance; Glucose Tolerance Test; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Nateglinide; Phenylalanine; Weight Loss | 2006 |
7 trial(s) available for phenylalanine and Hypoglycemia
Article | Year |
---|---|
Altered Caffeine Metabolism Is Associated With Recurrent Hypoglycemia in Type 2 Diabetes Mellitus: A UPLC-MS-Based Untargeted Metabolomics Study.
Topics: Biomarkers; Caffeine; Case-Control Studies; Chromatography, High Pressure Liquid; Chromatography, Liquid; Cortisone; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Phenylalanine; Tandem Mass Spectrometry | 2022 |
Nateglinide combination therapy with basal insulin and metformin in patients with Type 2 diabetes.
Topics: Adult; Aged; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period; Young Adult | 2009 |
Efficacy and safety of nateglinide in type 2 diabetic patients with modest fasting hyperglycemia.
Topics: Adult; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Incidence; Insulin; Insulin Secretion; Male; Nateglinide; Phenylalanine; Racial Groups; Treatment Outcome | 2002 |
Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Exercise Test; Female; Glucagon; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period | 2006 |
Efficacy and adverse effects of nateglinide in early type 2 diabetes. Comparison with voglibose in a cross-over study.
Topics: Aged; alpha-Glucosidases; Appetite; Body Weight; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Gastrointestinal Tract; Glycated Hemoglobin; Humans; Hypoglycemia; Inositol; Lipids; Liver Function Tests; Male; Middle Aged; Nateglinide; Phenylalanine; Treatment Outcome | 2006 |
Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results.
Topics: Aged; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Nateglinide; Phenylalanine; Safety; Time Factors | 2007 |
Nateglinide, alone or in combination with metformin, is effective and well tolerated in treatment-naïve elderly patients with type 2 diabetes.
Topics: Aged; Aged, 80 and over; Blood Glucose; Body Mass Index; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Nateglinide; Phenylalanine; Treatment Outcome | 2008 |
14 other study(ies) available for phenylalanine and Hypoglycemia
Article | Year |
---|---|
Biomedical Informatics Approaches to Identifying Drug-Drug Interactions: Application to Insulin Secretagogues.
Topics: Area Under Curve; Carbamates; Cyclohexanes; Databases, Factual; Diabetes Mellitus, Type 2; Drug Interactions; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Medical Informatics; Nateglinide; Pharmacoepidemiology; Phenylalanine; Piperidines; Sulfonylurea Compounds | 2017 |
Hypoglycaemia with oral antidiabetic drugs: results from prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide.
Topics: Administration, Oral; Adult; Adverse Drug Reaction Reporting Systems; Carbamates; Cohort Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Monitoring; Drug Prescriptions; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Male; Middle Aged; Nateglinide; Phenylalanine; Pioglitazone; Piperidines; Rosiglitazone; Sex Factors; Thiazolidinediones | 2009 |
Hypoglycemia due to nateglinide administration in diabetic patient with chronic renal failure.
Topics: Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Kidney Failure, Chronic; Middle Aged; Nateglinide; Phenylalanine | 2003 |
Hypoglycemia complicating treatment of phenylketonuria with a phenylalanine-deficient diet; report of two cases.
Topics: Diet; Humans; Hypoglycemia; Phenylalanine; Phenylketonurias | 1959 |
[HYPOGLYCEMIC REACTION TO LEUCINE, VALINE AND PHENYLALANINE IN A CASE OF DIFFUSE HYPERPLASIA OF THE BETA CELLS].
Topics: Glucose Tolerance Test; Humans; Hyperinsulinism; Hyperplasia; Hypoglycemia; Hypoglycemic Agents; Insulin-Secreting Cells; Islands; Islets of Langerhans; Leucine; Pathology; Pharmacology; Phenylalanine; Tolbutamide; Valine | 1963 |
[Achieving better control of blood sugar--understanding of oral hypoglycemic agents according to their characteristics in pharmacological action mechanism (discussion)].
Topics: Administration, Oral; Cardiovascular Diseases; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Indoles; Inositol; Insulin; Insulin Resistance; Insulin Secretion; Isoindoles; Nateglinide; Phenylalanine; Risk Factors; Stimulation, Chemical; Sulfonylurea Compounds; Thiazolidinediones | 2004 |
Octreotide therapy for nateglinide-induced hypoglycemia.
Topics: Aged; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Female; Gastrointestinal Agents; Glucose; Humans; Hypoglycemia; Hypoglycemic Agents; Nateglinide; Octreotide; Phenylalanine; Treatment Outcome | 2007 |
A single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with the ability to cause growth hormone deficiency syndrome.
Topics: Animals; Cell Line; Cricetinae; Genetic Variation; Glycoproteins; Growth Disorders; Hypoglycemia; Lymphocytic choriomeningitis virus; Mice; Mice, Inbred C3H; Phenylalanine; Reassortant Viruses; Serine; Syndrome; Viral Proteins | 1996 |
Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
Topics: Animals; ATP-Binding Cassette Transporters; Binding, Competitive; Carbamates; Cell Membrane; Cell Separation; Cells, Cultured; Cyclohexanes; Glucose; Glyburide; Glycosyltransferases; Humans; Hypoglycemia; Hypoglycemic Agents; In Vitro Techniques; Insulin; Islets of Langerhans; KATP Channels; Kinetics; Male; Membrane Proteins; Nateglinide; Patch-Clamp Techniques; Phenylalanine; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Sprague-Dawley; Repressor Proteins; Saccharomyces cerevisiae Proteins; Sulfonylurea Compounds | 2000 |
Protein-induced hypoglycemia in a phenylketonuric patient.
Topics: Adolescent; Female; Humans; Hypoglycemia; Phenylalanine; Phenylketonurias | 1978 |
Evidence for a precursor in the biosynthesis of insulin.
Topics: Adenoma, Islet Cell; Amino Acid Sequence; Animals; Chromatography, Gel; Humans; Hypoglycemia; In Vitro Techniques; Insulin; Leucine; Phenylalanine; Rats; Tritium | 1967 |
[Tyrosinosis. Primary and secondary biochemical changes].
Topics: Age Factors; Amino Acid Metabolism, Inborn Errors; Child, Preschool; Diet Therapy; Glucagon; Glucose; Humans; Hypoglycemia; Infant; Infant, Newborn; Liver Function Tests; Methionine; Phenylalanine; Phosphates; Protein Biosynthesis; Rickets; Statistics as Topic; Thrombocytopenia; Time Factors; Tyrosine; Vomiting | 1972 |
Impaired glucose homeostasis in phenylketonurics.
Topics: Adolescent; Blood Glucose; Brain Diseases; Child; Child, Preschool; Glucose; Glucose Tolerance Test; Homeostasis; Humans; Hypoglycemia; Infant; Intellectual Disability; Male; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Starvation; Time Factors | 1973 |
Stimulation of pentose phosphate pathway dehydrogenase enzyme activities in ethionine-treated mice.
Topics: Adenosine Triphosphate; Animals; Antimetabolites; Blood Glucose; Dactinomycin; Ethionine; Fluorouracil; Galactose; Glucose; Glucosephosphate Dehydrogenase; Glucosyltransferases; Glycogen; Hypoglycemia; Liver Glycogen; Mice; Phenylalanine; Phosphogluconate Dehydrogenase; Puromycin; Time Factors | 1968 |